Log in to save to my catalogue

Endothelial cell infection and dysfunction, immune activation in severe COVID-19

Endothelial cell infection and dysfunction, immune activation in severe COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8315069

Endothelial cell infection and dysfunction, immune activation in severe COVID-19

About this item

Full title

Endothelial cell infection and dysfunction, immune activation in severe COVID-19

Publisher

Australia: Ivyspring International Publisher Pty Ltd

Journal title

Theranostics, 2021-01, Vol.11 (16), p.8076-8091

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher Pty Ltd

More information

Scope and Contents

Contents

: Pulmonary vascular endotheliitis, perivascular inflammation, and immune activation are observed in COVID-19 patients. While the initial SARS-CoV-2 infection mainly infects lung epithelial cells, whether it also infects endothelial cells (ECs) and to what extent SARS-CoV-2-mediated pulmonary vascular endotheliitis is associated with immune activat...

Alternative Titles

Full title

Endothelial cell infection and dysfunction, immune activation in severe COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8315069

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8315069

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.61810

How to access this item